Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angocin Anti-Infekt N vs standard antibiotics for acute uncomplicated cystitis
2010-022096-54Phase 3Completed
- Sponsor
- Repha
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Angocin Anti-Infekt N and trimethoprim + sulfamethoxazole in acute cystitis and uncomplicated urinary tract infection (UTI) (2 arms), sponsored by Repha. Primary endpoint: Bacteriological response at visit 3. Started Dec 2010; status: completed.
02
Drugs
Angocin Anti-Infekt Ntrimethoprim + sulfamethoxazole
03
Conditions
acute cystitisuncomplicated urinary tract infection (UTI)
Beyond the preview
Go deeper on 2010-022096-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022096-54.